OSI Systems, Inc., a vertically integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that the Spacelabs Healthcare division has received an order for…
Category: Saudi Arabia
Quick-Med, Foster complete joint development program for NIMBUS antimicrobial catheters
Quick-Med Technologies, Inc. (OTCBB:QMDT) announced today that it has successfully completed its joint development program with Foster Corporation, a member of PolyMedex Discovery Group, to collaborate in applying Quick-Med’s proprietary NIMBUS® technology…
Esprida creates software to improve patient care
Esprida Corporation, a leading remote device management platform solution provider, today announced its partnership with Careworx Inc., a technology vendor and consulting firm dedicated to working with long-term healthcare facilities. Powered by…
Pepex announces development of combined glucose monitoring and insulin delivery meter
Pepex Biomedical, Inc. has unveiled development of a next generation solution for insulin dependent diabetics which will combine regular glucose monitoring and insulin delivery for diabetes sufferers worldwide. The company is developing…
Ontario hospital implants powerful new defibrillator
Minimally invasive surgeries mean smaller scars, quicker recovery St. Michael’s Hospital today became the first in Ontario to implant a small but powerful new defibrillator into a patient’s chest. The defibrillator –…
U.S. pivotal clinical trial of Medtronic CoreValve begins
Medtronic, Inc. (NYSE: MDT) today announced the beginning of its Medtronic CoreValve® U.S. Pivotal clinical trial in the United States. The first CoreValve transcatheter aortic valve implantation (TAVI) procedure was performed by…
New Technology Could Slash Gene Sequencing Time
Scientists from Imperial College London are developing technology that could ultimately sequence a person’s genome in mere minutes, at a fraction of the cost of current commercial techniques. The researchers have patented…
CoreMatrix delivers new cloud based, integrated, on demand marketing solutions
CoreMatrix Systems™, one of the country’s leading cloud computing consulting and Software-as-a-Service (SaaS) development companies, announced today that it has developed and delivered two new integrated, on demand marketing solutions. Built on…
AutoGenomics introduces first automated molecular assay for Familial Mediterranean Fever
AutoGenomics, a leader in providing automated, molecular testing solutions, announced today that it has launched a new test for the identification of genetic mutations implicated in the development of Familial Mediterranean Fever…
Wishard enters partnership with SIS to deliver perioperative services
Wishard Health Services (“Wishard”) has expanded its partnership with Surgical Information Systems (‘SIS”) by adding anesthesia, business intelligence and patient tracking capabilities to its existing SIS perioperative system. Wishard Health Services is…
Gastric bypass surgeries performed using da Vinci Surgical System
Friday, bariatric surgeons at St. Vincent’s East, Lee Schmitt, M.D., F.A.C.S. and Robert (Les) Miles, M.D., F.A.C.S., of Alabama Weight Loss Surgery, performed two gastric bypass surgeries using the da Vinci® Surgical…
Ovarian cancer tissue and healthy tissue smell different
György Horvath from the University of Gothenburg, Sweden, and researchers from the University of Gävle and KTH Royal Institute of Technology have been able to confirm in tests that ovarian cancer tissue…
New CPT code for use with T-SPOT.TB test
Oxford Immunotec, Inc. announces that a new and specific Current Procedural Terminology (CPT®) code has been established by the American Medical Association for use with the T-SPOT®.TB test. The new Category I…
Diopsys announces development of SD-OCT imaging technique to assist ophthalmologists
Diopsys, Inc. today announced the development of software that uses existing Spectral Domain Optical Coherence Tomography (SD-OCT) images to assist ophthalmologists and optometrists in diagnosing retinal and optic nerve disease such as…
New predictive medicine product for hereditary pancreatic and related cancers
Myriad Genetics, Inc. (Nasdaq:MYGN) today announced the launch of PANEXIA™, a predictive medicine product for hereditary pancreatic and related cancers. PANEXIA is a comprehensive analysis of the PALB2 and BRCA2 genes for…